Our Country Medicine Biological Enterprise R&d Input Research On The Influence Of The Market Share

With the transition to innovative economic in our country, the role of innovation that is the main driving force in the enterprise and market economy is paid attention and studied by more and more people. The medicine biotechnology industry has the characteristic of high technology, so its requirement of innovation is more intense. Currently, foreign enterprise has put the technology innovation activity as an important part of the enterprise development strategy and invested a huge number of human, material and financial resources into technology innovation activity, but the investment of technology innovation activity in our country enterprise is still low. The R&D activity is an important part of technical innovation. So should the enterprise attach importance to the R&D activity? Does the R&D investment affect enterprise’s sustainable development ability and business performance? How dose it influence specifically if this influence exists? Based on the above, this article made systematic research on R&D investment and market share, by selecting the market share index which can reflect competitive advantage and management performance of enterprise. This study tries to deepen the mechanism research of the enterprise R&D investment, deepen the understanding of the enterprise development theory, make a clear development direction and provide the theory basis to make scientific development strategy for the Chinese medicine biotechnology enterprise.The article consists of4chapters:The first chapter is the introduction. This chapter describes the research background and the significance first, and then based on the related literatures it describes the research purpose, the research contents, the research methods, technical route, the possible innovation and insufficiency.The second chapter is theoretical analysis of the effect from R&D investment to market share. This chapter structures a theoretical frame for the analysis the effect from R&D investment to market share on the basis of the study on the impact from R&D and market share to enterprise. It subdivides R&D into process R&D and product R&D, and discusses the influence mechanism from R&D investment to market share by Bertrand model.The third chapter is the empirical analysis of the effect from R&D investment to market share. Combined with the present situation of R&D investment and market share in our country medicine biological enterprises, this part uses the data of28listed companies in the medicine biotechnology industry during2007-2009to build a multivariate linear regression equation in order to validate the correlation and lagging between R&D investment and market share.The fourth chapter is the brief study conclusion.Research results show that:Firstly, the correlation between R&D expenditure and market share is positive, so enterprises should take technology innovation to the strategy first, increase the R&D expenditure and make enterprise have sustained competitiveness. Secondly, technicians input on the influence of the market share is not obvious, that shows the structure and quality of our R&D team need to improve. Thirdly, because new drugs produced by medicine biotechnology industry in our country are mainly imitative. that have quick effect and short cycle characteristics, the influence from R&D investment to market share is not lagging. But lots of experience research shows that original technology decides the competitive advantages of enterprises. So, from the long-term benefits, modern enterprise should use the independent R&D to improve the competitiveness of enterprises.